OKITASK Film-coated tablet Ref.[50400] Active ingredients: Ketoprofen

Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: Dompé Farmaceutici S.p.A., Via San Martino 12-12/a, 20122 Milano, Italy

Product name and form

Okitask 25 mg Film-Coated Tablets.

Pharmaceutical Form
Film-Coated Tablet. Round, convex, 7 mm diameter, blue film-coated tablets, with a non-functional score line on one side. The score line is not intended for breaking the tablet.

Qualitative and quantitative composition

Each tablet contains 25 mg ketoprofen 25 mg (as lysine salt).

For the full list of excipients, see section 6.1.

Active Ingredient	Description
Ketoprofen	Ketoprofen is a non-steroidal anti-inflammatory drug. It has anti-inflammatory and analgesic actions.

List of Excipients
Tablet core: Mannitol (E421) Crospovidone Sodium laurilsulfate Silica, colloidal anhydrous Sodium stearyl fumarate Coating: Polyvinyl alcohol (E1203) Macrogol Titanium dioxide (E171) Talc (E553B) Brilliant Blue (E133) Quinoline Yellow (E104)

Pack sizes and marketing

Opaque, Al/PA/Al/PVC blister in the following pack sizes: 8, 10, 15, 16, 20 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Dompé Farmaceutici S.p.A., Via San Martino 12-12/a, 20122 Milano, Italy

Marketing authorization dates and numbers

PA23072/001/002

Date of first authorisation: 12^th April 2019

Drugs

Drug	Countries
OKITASK	Estonia, Croatia, Ireland, Lithuania, Poland

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.